These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23684355)

  • 1. A comparative study on the activities of six combination regimens against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
    Zheng M; Jin H; Fu L; Xu J; Wang B; Zhao W; Zhu H; Li P; Lu Y; Li Q
    J Chemother; 2013 Apr; 25(2):81-6. PubMed ID: 23684355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice.
    Zhao W; Guo Z; Zheng M; Zhang J; Wang B; Li P; Fu L; Liu S
    Int J Antimicrob Agents; 2014 Feb; 43(2):148-53. PubMed ID: 24290060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo.
    Veziris N; Truffot-Pernot C; Aubry A; Jarlier V; Lounis N
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3117-22. PubMed ID: 14506018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model.
    Pieterman ED; Te Brake LHM; de Knegt GJ; van der Meijden A; Alffenaar JC; Bax HI; Aarnoutse RE; de Steenwinkel JEM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model.
    Gupta UD; Vemuri N; Gupta P; Kumar V; Tanushree P; Khuller GK
    Indian J Med Res; 2015 Sep; 142(3):323-9. PubMed ID: 26458349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.
    Liu Y; Pertinez H; Davies GR; Gillespie SH; Coates AR; Hu Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
    Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
    Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.
    Grosset JH; Tyagi S; Almeida DV; Converse PJ; Li SY; Ammerman NC; Bishai WR; Enarson D; Trébucq A
    Am J Respir Crit Care Med; 2013 Sep; 188(5):608-12. PubMed ID: 23822735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage therapy for multidrug-resistant tuberculosis.
    Seung KJ; Becerra MC; Atwood SS; Alcántara F; Bonilla CA; Mitnick CD
    Clin Microbiol Infect; 2014 May; 20(5):441-6. PubMed ID: 23991934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB; Jiang RH; Xiao HP
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis.
    Zhang Y; Liu J; Wang Y; Xian Q; Shao L; Yang Z; Wang X
    Sci China Life Sci; 2012 Sep; 55(9):800-6. PubMed ID: 23015129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.
    Lee BY; Clemens DL; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    Nat Commun; 2017 Jan; 8():14183. PubMed ID: 28117835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
    Swanson RV; Ammerman NC; Ngcobo B; Adamson J; Moodley C; Dorasamy A; Moodley S; Mgaga Z; Bester LA; Singh SD; Almeida DV; Grosset JH
    Antimicrob Agents Chemother; 2016 May; 60(5):2864-9. PubMed ID: 26926638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.